IntrinsicIntrinsic
← Scroll for more →

Financial Statements — TBN

Balance Sheet

(in millions USD)
MetricQ3 2026Q2 2026Q1 2026Q3 2025Q2 2025Q1 2025
Cash & Equivalents88.1583.4039.5625.6459.4474.04
Total Current Assets118.11106.3646.4637.9567.3189.96
Property, Plant & Equipment0.600.530.350.240.220.07
Total Non-current Assets553.96494.19437.71343.58295.61291.26
Total Assets672.06600.55484.16381.52362.92381.22
Accounts Payable42.8338.4131.1220.3722.5716.13
Total Current Liabilities59.1052.9650.3234.3838.0534.71
Long-term Debt44.5832.59--------
Total Non-current Liabilities66.3956.8518.4821.8115.8219.47
Total Liabilities125.48109.8068.8056.1953.8754.18
Retained Earnings(191.48)(182.08)(175.46)(157.10)(150.44)(136.27)
Total Stockholder Equity395.55358.86295.15239.85243.88275.60
← Scroll for more columns →

Income Statement

(in millions USD) (except per-share rows)
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Total Revenue0.000.000.000.000.000.000.000.00
Research & Development(0.23)0.030.140.190.821.983.23--
Selling, General & Admin1.861.521.691.601.511.471.401.41
Total Operating Expenses8.298.377.808.218.528.8015.016.98
Operating Income(8.29)(8.37)(7.80)(8.20)(8.52)(8.80)(15.01)(6.98)
Net Income(1.87)(9.41)(6.61)(8.18)(10.18)(6.66)(14.17)(5.89)
Basic EPS--(0.42)(0.33)(0.47)(0.65)(0.46)(0.99)(0.42)
Diluted EPS--(0.42)(0.33)(0.47)(0.65)(0.46)(0.99)(0.42)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Operating Cash Flow(7.56)(12.53)(0.71)(13.80)(6.43)(14.30)(4.75)(4.15)
Capital Expenditures0.160.050.170.040.060.030.2012.23
Free Cash Flow*(7.72)(12.58)(0.87)(13.84)(6.49)(14.34)(4.94)(16.38)
Investing Cash Flow(74.77)(46.25)(38.11)(28.43)(25.09)(37.88)(21.31)(14.50)
Financing Cash Flow218.2260.5595.5637.9452.7116.9814.6216.74
← Scroll for more columns →

* Derived from reported values